HEADER HYDROLASE 05-JUN-08 2VVC TITLE AMINOPYRROLIDINE FACTOR XA INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIVATED FACTOR XA HEAVY CHAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PEPTIDASE S1 DOMAIN, RESIDUES 235-475; COMPND 5 EC: 3.4.21.6; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: FACTOR X LIGHT CHAIN; COMPND 10 CHAIN: K, L; COMPND 11 FRAGMENT: EGF2, RESIDUES 126-180; COMPND 12 EC: 3.4.21.6; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE, ZYMOGEN, PROTEASE, GLYCOPROTEIN, GAMMA-CARBOXYGLUTAMIC KEYWDS 2 ACID, BLOOD CLOTTING, COAGULATION FACTOR, HYDROXYLATION, SERINE KEYWDS 3 PROTEASE, EGF-LIKE DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR K.GROEBKE-ZBINDEN,D.W.BANNER,J.M.BENZ,F.BLASCO,G.DECORET,J.HIMBER, AUTHOR 2 B.KUHN,N.PANDAY,F.RICKLIN,P.RISCH,D.SCHLATTER,M.STAHL,R.UNGER,W.HAAP REVDAT 5 20-NOV-24 2VVC 1 REMARK REVDAT 4 13-DEC-23 2VVC 1 REMARK LINK REVDAT 3 28-JUN-17 2VVC 1 REMARK REVDAT 2 13-JUL-11 2VVC 1 VERSN REVDAT 1 07-JUL-09 2VVC 0 JRNL AUTH K.G.ZBINDEN,L.ANSELM,D.W.BANNER,J.M.BENZ,F.BLASCO,G.DECORET, JRNL AUTH 2 J.HIMBER,B.KUHN,N.PANDAY,F.RICKLIN,P.RISCH,D.SCHLATTER, JRNL AUTH 3 M.STAHL,S.THOMI,R.UNGER,W.HAAP JRNL TITL DESIGN OF NOVEL AMINOPYRROLIDINE FACTOR XA INHIBITORS FROM A JRNL TITL 2 SCREENING HIT. JRNL REF EUR.J.MED.CHEM. V. 44 2787 2009 JRNL REFN ISSN 0223-5234 JRNL PMID 19200624 JRNL DOI 10.1016/J.EJMECH.2008.12.025 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.4.0067 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 74.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 34654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1849 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2590 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE SET COUNT : 143 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4396 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 574 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : UNVERIFIED REMARK 3 FROM WILSON PLOT (A**2) : 28.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.11000 REMARK 3 B22 (A**2) : 0.38000 REMARK 3 B33 (A**2) : -0.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.76000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.240 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.213 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.160 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.508 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4619 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6240 ; 1.487 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 564 ; 6.172 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 211 ;31.489 ;24.028 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 793 ;16.769 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;13.329 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 665 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3502 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2801 ; 0.644 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4503 ; 1.146 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1818 ; 1.824 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1737 ; 2.606 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : L 87 L 138 REMARK 3 ORIGIN FOR THE GROUP (A): -9.3290 -8.0710 51.1770 REMARK 3 T TENSOR REMARK 3 T11: -0.1846 T22: -0.1448 REMARK 3 T33: -0.1055 T12: -0.0213 REMARK 3 T13: 0.0385 T23: 0.0402 REMARK 3 L TENSOR REMARK 3 L11: 3.2593 L22: 1.5876 REMARK 3 L33: 3.8550 L12: -0.5458 REMARK 3 L13: -0.3644 L23: -1.1529 REMARK 3 S TENSOR REMARK 3 S11: -0.0192 S12: -0.4098 S13: -0.0417 REMARK 3 S21: 0.1222 S22: 0.0699 S23: 0.0585 REMARK 3 S31: -0.1336 S32: -0.1593 S33: -0.0507 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 16 A 243 REMARK 3 ORIGIN FOR THE GROUP (A): 3.0250 1.0890 32.3430 REMARK 3 T TENSOR REMARK 3 T11: -0.1509 T22: -0.1727 REMARK 3 T33: -0.1702 T12: -0.0155 REMARK 3 T13: 0.0254 T23: 0.0197 REMARK 3 L TENSOR REMARK 3 L11: 2.9126 L22: 1.4724 REMARK 3 L33: 1.2317 L12: 0.0347 REMARK 3 L13: 0.3686 L23: 0.0864 REMARK 3 S TENSOR REMARK 3 S11: -0.0509 S12: 0.3015 S13: 0.0697 REMARK 3 S21: -0.1619 S22: 0.0357 S23: 0.0330 REMARK 3 S31: -0.0564 S32: 0.0094 S33: 0.0152 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1244 A 1244 REMARK 3 RESIDUE RANGE : K 87 K 139 REMARK 3 ORIGIN FOR THE GROUP (A): 29.9620 21.1210 15.5150 REMARK 3 T TENSOR REMARK 3 T11: -0.1620 T22: -0.0444 REMARK 3 T33: -0.1014 T12: 0.0179 REMARK 3 T13: 0.0246 T23: -0.0411 REMARK 3 L TENSOR REMARK 3 L11: 0.9717 L22: 1.5923 REMARK 3 L33: 0.2728 L12: 0.7248 REMARK 3 L13: 0.4500 L23: 0.5102 REMARK 3 S TENSOR REMARK 3 S11: 0.0676 S12: 0.0613 S13: -0.0251 REMARK 3 S21: 0.0705 S22: 0.0231 S23: -0.0939 REMARK 3 S31: -0.0391 S32: 0.1005 S33: -0.0906 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 16 B 243 REMARK 3 ORIGIN FOR THE GROUP (A): 18.4380 14.3970 -4.1720 REMARK 3 T TENSOR REMARK 3 T11: -0.0453 T22: -0.1245 REMARK 3 T33: -0.1192 T12: -0.0047 REMARK 3 T13: 0.0175 T23: -0.0173 REMARK 3 L TENSOR REMARK 3 L11: 2.0513 L22: 1.3184 REMARK 3 L33: 1.9382 L12: 0.3052 REMARK 3 L13: -0.0305 L23: 0.0591 REMARK 3 S TENSOR REMARK 3 S11: -0.0706 S12: 0.1461 S13: -0.1386 REMARK 3 S21: -0.2066 S22: 0.0374 S23: 0.0703 REMARK 3 S31: 0.1529 S32: -0.1210 S33: 0.0332 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1244 B 1244 REMARK 3 ORIGIN FOR THE GROUP (A): 6.5750 11.2180 -9.2190 REMARK 3 T TENSOR REMARK 3 T11: 0.0196 T22: -0.0078 REMARK 3 T33: -0.0030 T12: -0.0317 REMARK 3 T13: 0.0562 T23: -0.1320 REMARK 3 L TENSOR REMARK 3 L11: 10.5866 L22: 6.1561 REMARK 3 L33: 9.2715 L12: -7.8027 REMARK 3 L13: 9.3870 L23: -7.5385 REMARK 3 S TENSOR REMARK 3 S11: 0.4323 S12: -0.2003 S13: 0.6824 REMARK 3 S21: -1.0109 S22: -0.4669 S23: 1.2870 REMARK 3 S31: 0.6819 S32: -0.0470 S33: 0.0346 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2VVC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUN-08. REMARK 100 THE DEPOSITION ID IS D_1290036472. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : OSMIC MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36457 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.3 REMARK 200 DATA REDUNDANCY : 3.660 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.54 REMARK 200 R MERGE FOR SHELL (I) : 0.38000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.030 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2BOK REMARK 200 REMARK 200 REMARK: ICE RING AT 2.26A EXCLUDED REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.59500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1910 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 372 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ARG 372 TO GLU REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 244 REMARK 465 ARG A 245 REMARK 465 GLY A 246 REMARK 465 LEU A 247 REMARK 465 PRO A 248 REMARK 465 LYS A 249 REMARK 465 ALA A 250 REMARK 465 LYS A 251 REMARK 465 ASP B 70 REMARK 465 ARG B 71 REMARK 465 ASN B 72 REMARK 465 THR B 73 REMARK 465 GLU B 74 REMARK 465 GLN B 75 REMARK 465 GLU B 76 REMARK 465 GLU B 77 REMARK 465 THR B 244 REMARK 465 ARG B 245 REMARK 465 GLY B 246 REMARK 465 LEU B 247 REMARK 465 PRO B 248 REMARK 465 LYS B 249 REMARK 465 ALA B 250 REMARK 465 LYS B 251 REMARK 465 ARG K 140 REMARK 465 ARG L 86 REMARK 465 ARG L 139 REMARK 465 ARG L 140 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG K 139 CA C O CB CG CD NE REMARK 470 ARG K 139 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2152 O HOH A 2220 2.03 REMARK 500 O HOH A 2121 O HOH A 2122 2.07 REMARK 500 O HOH A 2082 O HOH A 2218 2.08 REMARK 500 NH2 ARG A 93 O HOH A 2109 2.16 REMARK 500 O HOH A 2218 O HOH A 2222 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2084 O HOH B 2123 2545 2.13 REMARK 500 O HOH B 2070 O HOH B 2180 2645 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 22 CB CYS A 22 SG -0.105 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 27 59.98 -144.62 REMARK 500 ASN A 35 -167.16 -73.03 REMARK 500 GLU A 37 24.02 -70.92 REMARK 500 ASN A 38 13.20 53.84 REMARK 500 PHE A 41 -11.19 -140.21 REMARK 500 ALA A 61A 140.86 167.93 REMARK 500 TYR A 99 16.91 59.48 REMARK 500 ARG A 115 -177.59 -172.51 REMARK 500 LYS A 204 65.81 36.43 REMARK 500 SER A 214 -60.01 -122.79 REMARK 500 CYS B 27 46.04 -140.04 REMARK 500 ASN B 35 -167.78 -78.46 REMARK 500 ARG B 115 -174.85 -178.33 REMARK 500 ASN B 117 8.42 80.11 REMARK 500 SER B 195 139.85 -38.37 REMARK 500 LYS B 204 56.74 39.69 REMARK 500 GLN K 98 -109.50 -127.47 REMARK 500 GLU K 138 -108.60 -74.76 REMARK 500 GLN L 98 -117.20 -130.41 REMARK 500 GLN L 104 50.15 73.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2028 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH A2040 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH A2083 DISTANCE = 7.28 ANGSTROMS REMARK 525 HOH B2011 DISTANCE = 5.93 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1245 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 70 OD1 REMARK 620 2 ASN A 72 O 90.5 REMARK 620 3 GLN A 75 O 151.6 62.8 REMARK 620 4 GLU A 80 OE2 93.3 174.1 114.2 REMARK 620 5 HOH A2070 O 74.2 75.2 88.9 110.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A1246 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 185A O REMARK 620 2 TYR A 185 O 77.2 REMARK 620 3 ARG A 222 O 91.0 168.1 REMARK 620 4 LYS A 224 O 117.0 90.5 96.0 REMARK 620 5 HOH A2225 O 94.0 96.7 82.9 148.9 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B1245 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 TYR B 185 O REMARK 620 2 ARG B 222 O 157.6 REMARK 620 3 LYS B 224 O 90.5 93.0 REMARK 620 4 HOH B2171 O 98.4 81.1 169.3 REMARK 620 5 HOH B2176 O 102.2 99.8 70.4 101.7 REMARK 620 N 1 2 3 4 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 7-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 8-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BB" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LZF A 1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LZF B 1244 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 1246 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 1245 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WU1 RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 4 -[(5-CHLOROINDOL-2-YL) REMARK 900 SULFONYL]-2-(2- METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN -2-YL] REMARK 900 CARBONYL]PIPERAZINE REMARK 900 RELATED ID: 2J34 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 2BQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43 REMARK 900 RELATED ID: 2W3K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED REMARK 900 PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 1 REMARK 900 RELATED ID: 2VWO RELATED DB: PDB REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR REMARK 900 RELATED ID: 1XKA RELATED DB: PDB REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'- REMARK 900 AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID REMARK 900 RELATED ID: 1NFW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH REMARK 900 RPR209685 REMARK 900 RELATED ID: 2VVV RELATED DB: PDB REMARK 900 AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR REMARK 900 RELATED ID: 2GD4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA- REMARK 900 PENTASACCHARIDE COMPLEX REMARK 900 RELATED ID: 1MSX RELATED DB: PDB REMARK 900 HUMAN FACTOR XA COMPLEXED WITH 2-[3-(15N- AMINO-15N-IMINO-13C- REMARK 900 METHYL)PHENOXY]-6-[3 -(15N-AMINO-13C-METHYL)PHENOXY]-3,5- DIFLUORO- REMARK 900 4-METHYLPYRIDINE (ZK-806299), BINDING MODELFROM DOUBLE REDOR NMR REMARK 900 AND MD SIMULATIONS. REMARK 900 RELATED ID: 1LPG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79. REMARK 900 RELATED ID: 2VVU RELATED DB: PDB REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR REMARK 900 RELATED ID: 1P0S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEXWITH REMARK 900 ECOTIN M84R REMARK 900 RELATED ID: 2G00 RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 3 -(6-(2'-((DIMETHYLAMINO) REMARK 900 METHYL)-4-BIPHENYLYL )-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7- REMARK 900 TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1- YL)BENZAMIDE REMARK 900 RELATED ID: 1MQ6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(5-CHLORO-2- REMARK 900 PYRIDINYL)AMINO]CARBONYL ]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2- REMARK 900 OXAZOLYL)METHYLAMINO]METHYL]-2- THIOPHENECARBOXAMIDE COMPLEXED WITH REMARK 900 HUMAN FACTOR XA REMARK 900 RELATED ID: 1XKB RELATED DB: PDB REMARK 900 FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S) -(3'- REMARK 900 AMIDINO-3- BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID REMARK 900 RELATED ID: 1IQE RELATED DB: PDB REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55590 REMARK 900 RELATED ID: 1G2M RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 2VH0 RELATED DB: PDB REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL REMARK 900 PYRROLIDIN-2- ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS REMARK 900 RELATED ID: 1NFY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH REMARK 900 RPR200095 REMARK 900 RELATED ID: 2UWL RELATED DB: PDB REMARK 900 SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND REMARK 900 FACTOR XA REMARK 900 RELATED ID: 2BOK RELATED DB: PDB REMARK 900 FACTOR XA - CATION REMARK 900 RELATED ID: 1LPZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41. REMARK 900 RELATED ID: 1HCG RELATED DB: PDB REMARK 900 BLOOD COAGULATION FACTOR XA REMARK 900 RELATED ID: 2W3I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4 ,4-DISUBSTITUTED REMARK 900 PYRROLIDINE-1,2- DICARBOXAMIDE INHIBITOR 2 REMARK 900 RELATED ID: 2JKH RELATED DB: PDB REMARK 900 FACTOR XA - CATION INHIBITOR COMPLEX REMARK 900 RELATED ID: 1Z6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA COMPLEXED TO RAZAXABAN REMARK 900 RELATED ID: 2UWP RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 1G2L RELATED DB: PDB REMARK 900 FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 1NFU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH REMARK 900 RPR132747 REMARK 900 RELATED ID: 1FAX RELATED DB: PDB REMARK 900 COAGULATION FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 2BQ6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21 REMARK 900 RELATED ID: 1IQF RELATED DB: PDB REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55165 REMARK 900 RELATED ID: 1NL8 RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX REMARK 900 RELATED ID: 1IQG RELATED DB: PDB REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55159 REMARK 900 RELATED ID: 1IQH RELATED DB: PDB REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55143 REMARK 900 RELATED ID: 1LQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45. REMARK 900 RELATED ID: 2UWO RELATED DB: PDB REMARK 900 SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND REMARK 900 FACTOR XA REMARK 900 RELATED ID: 1C5M RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, REMARK 900 SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR REMARK 900 RELATED ID: 1IOE RELATED DB: PDB REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55532 REMARK 900 RELATED ID: 1F0S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH REMARK 900 RPR208707 REMARK 900 RELATED ID: 1F0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH REMARK 900 RPR208815 REMARK 900 RELATED ID: 2BMG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50 REMARK 900 RELATED ID: 1MQ5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO -2-[[(4-CHLOROPHENYL) REMARK 900 AMINO]CARBONYL]PHENYL]- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2- REMARK 900 THIOPHENECARBOXAMIDE COMPLEXED WITHHUMAN FACTOR XA REMARK 900 RELATED ID: 1IQN RELATED DB: PDB REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXD WITH M55192 REMARK 900 RELATED ID: 2BQW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45 REMARK 900 RELATED ID: 1IQM RELATED DB: PDB REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M54471 REMARK 900 RELATED ID: 1EZQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH REMARK 900 RPR128515 REMARK 900 RELATED ID: 2VWL RELATED DB: PDB REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR REMARK 900 RELATED ID: 2VH6 RELATED DB: PDB REMARK 900 STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: REMARK 900 PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS REMARK 900 RELATED ID: 1FJS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031)COMPLEXED REMARK 900 WITH FACTOR XA REMARK 900 RELATED ID: 1LPK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125. REMARK 900 RELATED ID: 2J4I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 1NFX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXEDWITH REMARK 900 RPR208944 REMARK 900 RELATED ID: 2VWN RELATED DB: PDB REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR REMARK 900 RELATED ID: 2J94 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 1IQJ RELATED DB: PDB REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55124 REMARK 900 RELATED ID: 2J95 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 2CJI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 2BOH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 1 REMARK 900 RELATED ID: 2J38 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 2W26 RELATED DB: PDB REMARK 900 FATOR XA IN COMPLEX WITH BAY59-7939 REMARK 900 RELATED ID: 1IQI RELATED DB: PDB REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55125 REMARK 900 RELATED ID: 2VWM RELATED DB: PDB REMARK 900 AMINOPYRROLIDINE FACTOR XA INHIBITOR REMARK 900 RELATED ID: 1KYE RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH (R)-2-(3- ADAMANTAN-1-YL-UREIDO)-3-(3- REMARK 900 CARBAMIMIDOYL- PHENYL)-N-PHENETHYL-PROPIONAMIDE REMARK 900 RELATED ID: 1IQK RELATED DB: PDB REMARK 900 HUNMAN COAGULATION FACTOR XA COMPLEXD WITH M55113 REMARK 900 RELATED ID: 1V3X RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -[6-METHYL-4,5,6,7- REMARK 900 TETRAHYDROTHIAZOLO(5, 4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4 -(6- REMARK 900 CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE REMARK 900 RELATED ID: 2FZZ RELATED DB: PDB REMARK 900 FACTOR XA IN COMPLEX WITH THE INHIBITOR 1 -(3-AMINO-1,2- REMARK 900 BENZISOXAZOL-5-YL)-6-(2 '-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4 REMARK 900 -BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6- TETRAHYDRO-7H-PYRAZOLO[3, REMARK 900 4-C]PYRIDIN-7-ONE REMARK 900 RELATED ID: 2J2U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX REMARK 900 RELATED ID: 1IQL RELATED DB: PDB REMARK 900 HUMAN COAGULATION FACTOR XA COMPLEXED WITH M54476 REMARK 900 RELATED ID: 1KSN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH REMARK 900 FXV673 REMARK 999 REMARK 999 SEQUENCE REMARK 999 ARG-GLU MUTANT.THE RESIDUE NUMBERING IN THE CATALYTIC REMARK 999 DOMAIN FOLLOWS THAT OF CHYMOTRYPSINOGEN DBREF 2VVC A 16 251 UNP P00742 FA10_HUMAN 235 475 DBREF 2VVC B 16 251 UNP P00742 FA10_HUMAN 235 475 DBREF 2VVC K 86 140 UNP P00742 FA10_HUMAN 126 180 DBREF 2VVC L 86 140 UNP P00742 FA10_HUMAN 126 180 SEQADV 2VVC GLU A 150 UNP P00742 ARG 372 ENGINEERED MUTATION SEQADV 2VVC GLU B 150 UNP P00742 ARG 372 ENGINEERED MUTATION SEQRES 1 A 241 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 A 241 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 A 241 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 A 241 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 A 241 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 A 241 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 A 241 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 A 241 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 A 241 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 A 241 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 A 241 GLY ARG THR HIS GLU LYS GLY GLU GLN SER THR ARG LEU SEQRES 12 A 241 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 A 241 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 A 241 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 A 241 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 A 241 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 A 241 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 A 241 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 A 241 ARG GLY LEU PRO LYS ALA LYS SEQRES 1 B 241 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 B 241 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 B 241 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 B 241 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 B 241 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 B 241 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 B 241 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 B 241 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 B 241 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 B 241 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 B 241 GLY ARG THR HIS GLU LYS GLY GLU GLN SER THR ARG LEU SEQRES 12 B 241 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 B 241 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 B 241 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 B 241 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 B 241 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 B 241 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 B 241 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 19 B 241 ARG GLY LEU PRO LYS ALA LYS SEQRES 1 K 55 ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP GLN SEQRES 2 K 55 PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER CYS SEQRES 3 K 55 ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA CYS SEQRES 4 K 55 ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR LEU SEQRES 5 K 55 GLU ARG ARG SEQRES 1 L 55 ARG LYS LEU CYS SER LEU ASP ASN GLY ASP CYS ASP GLN SEQRES 2 L 55 PHE CYS HIS GLU GLU GLN ASN SER VAL VAL CYS SER CYS SEQRES 3 L 55 ALA ARG GLY TYR THR LEU ALA ASP ASN GLY LYS ALA CYS SEQRES 4 L 55 ILE PRO THR GLY PRO TYR PRO CYS GLY LYS GLN THR LEU SEQRES 5 L 55 GLU ARG ARG HET LZF A1244 34 HET CA A1245 1 HET NA A1246 1 HET LZF B1244 34 HET NA B1245 1 HETNAM LZF 5-CHLORO-N-[(3S,4S)-1-(2-{[2-FLUORO-4-(2-OXOPYRIDIN- HETNAM 2 LZF 1(2H)-YL)PHENYL]AMINO}-2-OXOETHYL)-4- HETNAM 3 LZF METHOXYPYRROLIDIN-3-YL]THIOPHENE-2-CARBOXAMIDE HETNAM CA CALCIUM ION HETNAM NA SODIUM ION FORMUL 5 LZF 2(C23 H22 CL F N4 O4 S) FORMUL 6 CA CA 2+ FORMUL 7 NA 2(NA 1+) FORMUL 10 HOH *574(H2 O) HELIX 1 1 ALA A 55 GLN A 61 5 7 HELIX 2 2 GLU A 124A LEU A 131A 1 9 HELIX 3 3 ASP A 164 SER A 172 1 9 HELIX 4 4 PHE A 234 LYS A 243 1 10 HELIX 5 5 ALA B 55 GLN B 61 5 7 HELIX 6 6 GLU B 124A LEU B 131A 1 9 HELIX 7 7 ASP B 164 SER B 171 1 8 HELIX 8 8 PHE B 234 LYS B 243 1 10 HELIX 9 9 LEU K 91 CYS K 96 5 6 HELIX 10 10 LEU L 91 CYS L 96 5 6 SHEET 1 AA 9 GLN A 20 GLU A 21 0 SHEET 2 AA 9 LYS A 156 VAL A 163 -1 O MET A 157 N GLN A 20 SHEET 3 AA 9 MET A 180 ALA A 183 -1 O CYS A 182 N VAL A 163 SHEET 4 AA 9 GLY A 226 LYS A 230 -1 O GLY A 226 N ALA A 183 SHEET 5 AA 9 THR A 206 TRP A 215 -1 O ILE A 212 N THR A 229 SHEET 6 AA 9 PRO A 198 PHE A 203 -1 O HIS A 199 N THR A 210 SHEET 7 AA 9 THR A 135 GLY A 140 -1 O ILE A 137 N VAL A 200 SHEET 8 AA 9 LYS A 156 VAL A 163 1 O LYS A 156 N GLY A 140 SHEET 9 AA 9 GLN A 20 GLU A 21 -1 O GLN A 20 N MET A 157 SHEET 1 AB 7 ALA A 81 HIS A 83 0 SHEET 2 AB 7 LYS A 65 VAL A 68 -1 O VAL A 66 N HIS A 83 SHEET 3 AB 7 GLN A 30 ILE A 34 -1 O LEU A 32 N ARG A 67 SHEET 4 AB 7 GLY A 40 ILE A 46 -1 N PHE A 41 O LEU A 33 SHEET 5 AB 7 TYR A 51 THR A 54 -1 O LEU A 53 N THR A 45 SHEET 6 AB 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 7 AB 7 VAL A 85 LYS A 90 -1 N GLU A 86 O ARG A 107 SHEET 1 BA 8 GLN B 20 GLU B 21 0 SHEET 2 BA 8 LYS B 156 VAL B 163 -1 O MET B 157 N GLN B 20 SHEET 3 BA 8 MET B 180 ALA B 183 -1 O CYS B 182 N VAL B 163 SHEET 4 BA 8 GLY B 226 LYS B 230 -1 O GLY B 226 N ALA B 183 SHEET 5 BA 8 THR B 206 TRP B 215 -1 O ILE B 212 N THR B 229 SHEET 6 BA 8 PRO B 198 PHE B 203 -1 O HIS B 199 N THR B 210 SHEET 7 BA 8 THR B 135 GLY B 140 -1 O ILE B 137 N VAL B 200 SHEET 8 BA 8 GLN B 20 GLU B 21 0 SHEET 1 BB 7 GLN B 30 ILE B 34 0 SHEET 2 BB 7 GLY B 40 SER B 48 -1 N PHE B 41 O LEU B 33 SHEET 3 BB 7 TYR B 51 THR B 54 -1 O TYR B 51 N LEU B 47 SHEET 4 BB 7 ALA B 104 LEU B 108 -1 O ALA B 104 N THR B 54 SHEET 5 BB 7 ALA B 81 LYS B 90 -1 N GLU B 86 O ARG B 107 SHEET 6 BB 7 LYS B 65 VAL B 68 -1 O VAL B 66 N HIS B 83 SHEET 7 BB 7 GLN B 30 ILE B 34 -1 O LEU B 32 N ARG B 67 SHEET 1 KA 2 PHE K 99 GLU K 103 0 SHEET 2 KA 2 SER K 106 SER K 110 -1 O SER K 106 N GLU K 103 SHEET 1 KB 2 TYR K 115 LEU K 117 0 SHEET 2 KB 2 CYS K 124 PRO K 126 -1 O ILE K 125 N THR K 116 SHEET 1 LA 2 PHE L 99 GLU L 102 0 SHEET 2 LA 2 VAL L 107 SER L 110 -1 O VAL L 108 N HIS L 101 SHEET 1 LB 2 TYR L 115 LEU L 117 0 SHEET 2 LB 2 CYS L 124 PRO L 126 -1 O ILE L 125 N THR L 116 SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.04 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.06 SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.06 SSBOND 4 CYS A 168 CYS A 182 1555 1555 1.98 SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.03 SSBOND 6 CYS B 22 CYS B 27 1555 1555 2.06 SSBOND 7 CYS B 42 CYS B 58 1555 1555 2.08 SSBOND 8 CYS B 122 CYS K 132 1555 1555 2.04 SSBOND 9 CYS B 168 CYS B 182 1555 1555 1.97 SSBOND 10 CYS B 191 CYS B 220 1555 1555 2.04 SSBOND 11 CYS K 89 CYS K 100 1555 1555 2.03 SSBOND 12 CYS K 96 CYS K 109 1555 1555 2.05 SSBOND 13 CYS K 111 CYS K 124 1555 1555 2.07 SSBOND 14 CYS L 89 CYS L 100 1555 1555 2.03 SSBOND 15 CYS L 96 CYS L 109 1555 1555 2.04 SSBOND 16 CYS L 111 CYS L 124 1555 1555 2.05 LINK OD1 ASP A 70 CA CA A1245 1555 1555 2.45 LINK O ASN A 72 CA CA A1245 1555 1555 2.37 LINK O GLN A 75 CA CA A1245 1555 1555 2.42 LINK OE2 GLU A 80 CA CA A1245 1555 1555 3.13 LINK O ASP A 185A NA NA A1246 1555 1555 2.43 LINK O TYR A 185 NA NA A1246 1555 1555 2.37 LINK O ARG A 222 NA NA A1246 1555 1555 2.25 LINK O LYS A 224 NA NA A1246 1555 1555 2.42 LINK CA CA A1245 O HOH A2070 1555 1555 3.12 LINK NA NA A1246 O HOH A2225 1555 1555 2.20 LINK O TYR B 185 NA NA B1245 1555 1555 2.37 LINK O ARG B 222 NA NA B1245 1555 1555 2.29 LINK O LYS B 224 NA NA B1245 1555 1555 2.29 LINK NA NA B1245 O HOH B2171 1555 1555 2.29 LINK NA NA B1245 O HOH B2176 1555 1555 2.42 SITE 1 AC1 16 GLU A 97 THR A 98 TYR A 99 GLU A 147 SITE 2 AC1 16 PHE A 174 ASP A 189 ALA A 190 GLN A 192 SITE 3 AC1 16 VAL A 213 TRP A 215 GLY A 216 GLY A 218 SITE 4 AC1 16 CYS A 220 GLY A 226 ILE A 227 TYR A 228 SITE 1 AC2 20 GLU B 97 THR B 98 GLU B 147 PHE B 174 SITE 2 AC2 20 ASP B 189 ALA B 190 GLN B 192 SER B 195 SITE 3 AC2 20 VAL B 213 TRP B 215 GLY B 216 GLU B 217 SITE 4 AC2 20 GLY B 218 CYS B 220 GLY B 226 ILE B 227 SITE 5 AC2 20 TYR B 228 HOH B2178 HOH B2188 HOH B2209 SITE 1 AC3 6 ASP A 70 ASN A 72 GLN A 75 GLU A 76 SITE 2 AC3 6 GLU A 77 GLU A 80 SITE 1 AC4 5 TYR A 185 ASP A 185A ARG A 222 LYS A 224 SITE 2 AC4 5 HOH A2225 SITE 1 AC5 6 TYR B 185 ASP B 185A ARG B 222 LYS B 224 SITE 2 AC5 6 HOH B2171 HOH B2176 CRYST1 48.960 77.190 74.760 90.00 92.12 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020425 0.000000 0.000756 0.00000 SCALE2 0.000000 0.012955 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013385 0.00000